Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Neoplasms of the CNS

  Free Subscription


17.08.2026

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
1 BMC Cancer
1 Cancer Res
2 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
2 J Neurooncol
1 J Neuropathol Exp Neurol
5 Neuro Oncol
1 Neurosurgery
1 Pediatr Neurol
3 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. GEHIN W, Merlin MS, Harle A, Merlin JL, et al
    Cerebrospinal fluid cell-free DNA sequencing in pediatric CNS tumors: towards liquid molecular neuropathology.
    Acta Neuropathol. 2026;152:18.
    PubMed         Abstract available


    AJNR Am J Neuroradiol

  2. SHAH SR, Qazi MS, Riyyan M, Hussain R, et al
    Diffusion Tensor Imaging Analysis Along the Perivascular Space (DTI-ALPS) as an Imaging Biomarker of Glymphatic Dysfunction in Gliomas: A Systematic Review and Meta-Analysis.
    AJNR Am J Neuroradiol. 2026 Aug 13:ajnr.A9593. doi: 10.3174/ajnr.A9593.
    PubMed         Abstract available


    BMC Cancer

  3. LIU CC, Yu CF, Wang SC, Li HY, et al
    Retraction Note: Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.
    BMC Cancer. 2026;26:985.
    PubMed        


    Cancer Res

  4. BACKLUND A, Samaniego CH, Rangaraj R, Campbell C, et al
    Ancestral Genetic Homogeneity in Preclinical Models May Shape Outcome Differences in Pediatric Brain Cancer.
    Cancer Res. 2026;86:3908-3919.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  5. TOM MC, Straube C, Breen WG, Cramer C, et al
    Redefining the Limits of Highly Conformal Radiation Therapy for Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2026;126:1-8.
    PubMed        

  6. BAILEY MM, Avery C, Hagen MC, Pater LE, et al
    An exploratory analysis of the association between progesterone use and tumor-related visual deficit in women with meningioma.
    Int J Radiat Oncol Biol Phys. 2026 Aug 14:S0360-3016(26)04146.
    PubMed         Abstract available


    J Clin Oncol

  7. KINSLOW CJ, Minniti G, Brown PD, Vogelbaum MA, et al
    Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.
    J Clin Oncol. 2026 Aug 12:JCO2501846. doi: 10.1200/JCO-25-01846.
    PubMed         Abstract available


    J Neurooncol

  8. DAMANTE MA, Juncker RB, Little AS, Van Gompel JJ, et al
    Molecular therapy for papillary craniopharyngioma: a multi-institutional analysis of practice patterns across the RAPID Consortium.
    J Neurooncol. 2026;179:40.
    PubMed         Abstract available

  9. KABIR AS, Peeran Z, Osorio RC, Shukla P, et al
    Socioeconomic factors associated with post-operative biochemical remission in acromegaly.
    J Neurooncol. 2026;179:37.
    PubMed         Abstract available


    J Neuropathol Exp Neurol

  10. YELDIR N, Sargolzaeimoghaddam M, Sargolzaeimoghaddam M, Cakir A, et al
    Proliferation patterns across meningioma locations: A WHO grade-based analysis.
    J Neuropathol Exp Neurol. 2026 Aug 13:nlag090. doi: 10.1093.
    PubMed         Abstract available


    Neuro Oncol

  11. KESARWANI A, Griffith AN, Verma S, Hu T, et al
    Siglec-15 and PD-1 checkpoint blockade in combination with oncolytic Zika virus infection confers protection against immune-resistant gliomas.
    Neuro Oncol. 2026 Aug 8:noag186. doi: 10.1093.
    PubMed         Abstract available

  12. BEN-MOUEL OS, Shemesh SZ, Dumanis G, Abofani H, et al
    Stereotactic Radiosurgery Outcomes for Radiation-Induced Meningiomas After Childhood Tinea Capitis Irradiation: A Comparative Study with Sporadic Meningiomas.
    Neuro Oncol. 2026 Aug 10:noag180. doi: 10.1093.
    PubMed         Abstract available

  13. AKHAVAN D, Yadav M, Subham S, Jeppson J, et al
    Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric Glioma.
    Neuro Oncol. 2026 Aug 10:noag185. doi: 10.1093.
    PubMed         Abstract available

  14. TZARIDIS T, Fernandez EC, Eisemann T, Liou A, et al
    CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.
    Neuro Oncol. 2026 Aug 10:noag178. doi: 10.1093.
    PubMed         Abstract available

  15. SCHMIDBAUER KJ, von Polenz I, Reis J, Wiegand L, et al
    PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative study.
    Neuro Oncol. 2026 Aug 14:noag182. doi: 10.1093.
    PubMed         Abstract available


    Neurosurgery

  16. GHOCHE MT, Miki K, Yuan F, Gecici NN, et al
    Perioperative Management of Targeted and Immunologic Agents in Neurosurgical Oncology.
    Neurosurgery. 2026 Feb 2. doi: 10.1227/neu.0000000000003930.
    PubMed         Abstract available


    Pediatr Neurol

  17. LO MONACO G, Marucci G, Valentini LG, Masnada S, et al
    Sylvian Fissure Meningioma in a Child With KRAS-Related Noonan Syndrome.
    Pediatr Neurol. 2026;183:164-166.
    PubMed        


    PLoS One

  18. MAJUMDER R, Datta P, Moolayadukkam S, Puri IK, et al
    Repurposing Alzheimer's and ovarian cancer drugs as sonosensitizers for glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new approach methodology (NAM).
    PLoS One. 2026;21:e0354981.
    PubMed         Abstract available


  19. Expression of concern: Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
    PLoS One. 2026;21:e0355894.
    PubMed        

  20. SANCHEZ-HERNANDEZ A, Burgaz S, Louzame-Ruano J, Laguia O, et al
    Targeting telomeres in brain vasculature does not impede initiation and progression of glioblastoma.
    PLoS One. 2026;21:e0355168.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  21. PUIGDELLOSES VALLCORBA M, Rawat K, Soni N, DiMauro A, et al
    Histone H3K27M variants determine myeloid subset dependencies and immune reprogramming in diffuse midline glioma.
    Proc Natl Acad Sci U S A. 2026;123:e2537768123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum